About Omnicals Pharma
Omnicals Pharma is a company based in Mumbai (India) founded in 2017 by Anurag Pathak. It operates as a B2B. The company has 14 employees. Omnicals Pharma operates in a competitive market with competitors including Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect, among others.
- Headquarter Mumbai, India
- Employees 14
- Founders Anurag Pathak
- SectorsHealthcare
- Website omnicals.com
- Legal Name Omnicals Pharma Private Limited
- Date of Incorporation 17 May, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹83.93 Cr
FY 2025 · +41% YoY
- Net Profit₹8.66 Cr
FY 2025 · 10% margin
- EBITDA₹11.37 Cr
FY 2025 · 14% margin
- Employee Count14
Associated legal entities of Omnicals Pharma
Omnicals Pharma operates through Omnicals Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Omnicals Pharma Private Limited CIN U33309MH2017PTC294976 | Active | 17 May 2017 | Mumbai, Maharashtra | ₹83.9 Cr | 14 | 4 | View details |
Board of directors of Omnicals Pharma Private Limited (Omnicals Pharma)
Omnicals Pharma Private Limited is the primary company behind Omnicals Pharma. The board of Omnicals Pharma Private Limited currently have 4 directors; the longest-serving is Rohit Dansingh Negi, appointed in 2017. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohit Dansingh Negi DIN 07751111 | Director | 17 May 2017 | 9 yrs 4 mo | Omnicals Pharma Private Limited |
| Anurag Bhoop Narayan Pathak DIN 06502835 | Managing Director | 08 Aug 2017 | 9 yrs 2 mo | Omnicals Pharma Private Limited |
| Anil Kashiram Fokmare DIN 09821185 | Director | 15 Dec 2022 | 3 yrs 9 mo | Omnicals Pharma Private Limited |
| Akshya Kumar Mahapatra DIN 08362446 | Additional Director | 15 Dec 2025 | 9 mo | Omnicals Pharma Private Limited |
People of Omnicals Pharma
1 people are tracked at Omnicals Pharma (1 in leadership); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
| Founder, CEO, Managing Director | Leadership |
Complete people profiles for Omnicals Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Omnicals Pharma
Figures of Omnicals Pharma Private Limited, the primary company behind Omnicals Pharma, for FY 2025. Revenue was ₹83.93 Cr (+41% year on year). Net profit was ₹8.66 Cr (10% margin). EBITDA was ₹11.37 Cr (14% margin). Revenue has grown at a compounded annual rate of +16% over three years and +84% over five years.
- ₹83.93 CrRevenue · FY 2025 · +41% YoY
- ₹8.66 CrNet profit · 10% margin
- ₹11.37 CrEBITDA · 14% margin
- ₹20.8 LakhPaid-up capital
- 14Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +84%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Omnicals Pharma Private Limited are on its company page.
Detailed financial statements for Omnicals Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Omnicals Pharma
Omnicals Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zevra.com | 2006 | Celebration, United States | – | 45 | Marketing services are provided to biopharma companies. | |
| sayretherapeutics.com | 2015 | Bengaluru, India | $7.9M | 23 | Access to therapies for rare and life-threatening diseases is provided. | |
| supremeopti.com | 2012 | San Juan, Puerto Rico | – | – | Digital marketing services are offered to the life sciences sector. | |
| andira.ca | 2020 | Vancouver, Canada | $1.43M | – | Digital pharmacotherapeutic platform for providers | |
| lifescienceconnect.com | 2009 | Erie, United States | – | – | Marketing and commercialization services for biopharma sector are provided. | |
| woodwardpharma.com | 2015 | Wixom, United States | – | – | Pharmaceutical company that provides outsourced marketing, sales, and commercial services for pharmaceutical companies | |
| ethosh.com | 2012 | Pune, India | $275,084 | 45 | Provider of digital experience and marketing services to health-tech and life-sciences organizations | |
| anpharmaceuticals.com | 2001 | Delhi, India | – | 71 | A pharmaceutical marketing company with a network in Delhi-NCR and UP. |
Detailed competitors of Omnicals Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Omnicals Pharma
10 companies that operate in the same segment as Omnicals Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Omnicals Pharma
Omnicals Pharma was founded in 2017.
Omnicals Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anurag Pathak is the current CEO of Omnicals Pharma. They have also founded this company.
Omnicals Pharma has 14 employees.
The primary company behind Omnicals Pharma, Omnicals Pharma Private Limited, reported revenue of ₹83.93 Cr for FY 2025, up 41% year on year.
Omnicals Pharma, established in 2017, excels in providing healthcare solutions, producing pharmaceutical products, marketing services, and product promotion. Provides marketing services for pharmaceutical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Omnicals Pharma's top competitors include Zevra, Sayre Therapeutics and Ethosh.
Omnicals Pharma operates through Omnicals Pharma Private Limited.
The legal entities of Omnicals Pharma currently have 4 directors, including Rohit Dansingh Negi, Anurag Bhoop Narayan Pathak, Anil Kashiram Fokmare and others.